Breaking News, Collaborations & Alliances

Societal CDMO Enters Manufacturing & Supply Agreement with InfectoPharm

Establishes Societal as the exclusive supplier of Ritalin LA capsules for the European market through 2023.

Author Image

By: Charlie Sternberg

Associate Editor

Societal CDMO Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, has entered into a three-year manufacturing and supply agreement with InfectoPharm for Ritalin LA capsules (methylphenidate hydrochloride extended-release capsules) in Europe.   The new agreement, which is effective immediately and runs through April 2025, establishes Societal as the exclusive...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters